SYSTEMATIC REVIEW
Accepted on 29 Jan 2025
Evaluating the Efficacy and Safety of Immune Checkpoint Inhibitors in First and Second-Line Treatments for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis of RCTs with a Focus on PD-L1 Expression
doi 10.3389/fimmu.2025.1508885